Science topic

Neurological Diseases - Science topic

Explore the latest questions and answers in Neurological Diseases, and find Neurological Diseases experts.
Questions related to Neurological Diseases
  • asked a question related to Neurological Diseases
Question
18 answers
In the identified case of familial desminopathy (T341P DES mutation in heterozygous state), the son has bradycardia, but the father did not have bradycardia. How can this fact be explained?
Relevant answer
Answer
Because of some autosomal dominant & others can be autosomal recessive
"Desminopathy is one of the most common intermediate filament human disorders associated with mutations in closely interacting proteins, desmin and alphaB-crystallin. The inheritance pattern in familial desminopathy is characterized as autosomal dominant or autosomal recessive, but many cases have no family history."
  • asked a question related to Neurological Diseases
Question
7 answers
It is known that patients with desminopathy often die from pneumonia. Have pathomorphological studies of the lungs been performed in patients with desminopathy?
Relevant answer
Answer
Dear Sagar Nanaso Salunkhe, thank you very much for your detailed answers!
  • asked a question related to Neurological Diseases
Question
3 answers
Hello all, my name is Gift Adene, I live in Nigeria, and I'm currently working on an exciting research aimed at developing a CNN model for detecting and predicting neurological diseases!
I'm on the lookout for high-quality and recent data sets that would be suitable for training and testing the CNN model. If you have access to any data sets related to neurological diseases (PD and/or AD preferably), I would love to hear from you!
Also, I'm seeking insights on which data set would be better suited for training the CNN model. Do you have any recommendations or suggestions on the most effective data sets for this purpose? Your expertise and input would be incredibly valuable.
Thanks in advance for your support and assistance, looking forward to a positive response.
#Research #Neurology #MachineLearning #DataScience #HelpNeeded #CNN #ConvolutionalNeuralNetworks
Relevant answer
Answer
It is necessary to determine the disease, and only then study its main clinical features, features of the results of instrumental and laboratory research methods, as well as genetic features.
  • asked a question related to Neurological Diseases
Question
8 answers
It is known that in the early stages of desminopathy the muscles most often affected are: Semitendinosus, Gracilis and Sartorius. What is the reason for the damage to these particular muscles?
Relevant answer
Answer
Desminopathy, also known as desmin-related myopathy (DRM), is a rare genetic muscle disorder that affects the protein desmin. Desmin is an essential component of the intermediate filaments that provide structural support within muscle cells. Mutations in the DES gene, which codes for desmin, lead to disruptions in the normal structure and function of muscle fibers.
The muscles you mentioned - Semitendinosus, Gracilis, and Sartorius - are often affected at the onset of desminopathy due to their specific characteristics and biomechanical roles.
1. Semitendinosus: The semitendinosus is one of the three hamstring muscles located in the back of the thigh. It plays a key role in knee flexion and hip extension. The semitendinosus muscle is frequently involved in desminopathy due to its high proportion of slow-twitch muscle fibers, which are more vulnerable to desmin-related abnormalities.
2. Gracilis: The gracilis muscle is a long, thin muscle located in the inner thigh region. It is involved in hip adduction and knee flexion. Similar to the semitendinosus, the gracilis muscle also consists of a high proportion of slow-twitch muscle fibers, making it susceptible to desmin-related abnormalities.
3. Sartorius: The sartorius muscle is a long, strap-like muscle that runs diagonally across the front of the thigh. It plays a role in hip and knee flexion and also assists in thigh rotation. The sartorius muscle is affected in desminopathy due to its similar composition of slow-twitch muscle fibers.
The predilection for these specific muscles in desminopathy may be attributed to their fiber type composition and the mechanical stress they experience during certain movements. However, it is important to note that desminopathy can affect other muscles as well, and the degree and pattern of muscle involvement may vary among individuals with the same genetic mutation.
It is advised to consult with a medical professional or genetics specialist for a more accurate assessment of muscle involvement and management of desminopathy.
  • asked a question related to Neurological Diseases
Question
6 answers
In a patient with desminopathy (mutation Thr341Pro DES in the heterozygous state) with the progression of the disease, we note signs and symptoms that are also characteristic of botulism: bradycardia, arrhythmia, AV blockade, a significant decrease in the average duration of motor unit potentials according to electroneuromyography, paresis and paralysis of the striated muscles, decreased sweating, paresis of the gastrointestinal tract, dry eyes, dry mouth, symmetry of neurological symptoms, hoarseness, impaired visual acuity, doubling of objects occurs, progressive muscle weakness. These signs and symptoms are characteristic of botulism, only when a case of desminopathy is detected, they proceed slowly.
Relevant answer
Answer
Your analogy is very interesting, dear colleague.
Although the main cause of any form of myofibrillar myopathy is a violation of the structure of the protein components of sarcomeres caused by genetic mutations, why not assume that due to mutations, the sensitivity of the postsynaptic membrane of myofibrils in myofibrillar myopathy to acetylcholine may also be impaired.
  • asked a question related to Neurological Diseases
Question
4 answers
When staining with hematoxylin and eosin of a muscle biopsy from a patient with T341P desminopathy, we observe accumulations of inclusions similar to nuclei (arrows in figures 1 and 2, x280). And outside of these accumulations - adipose tissue, which used to be muscle tissue. There are no such massive accumulations of inclusions in adjacent muscle fibers. We assume that clusters of inclusions are not nuclei? Figure 2 is the inverted figure 1.
Relevant answer
Answer
Dear Geir Bjorklund, Duc M. Hoang, John Hildyard, thank you very much for your answers and recommendations!
  • asked a question related to Neurological Diseases
Question
2 answers
I want to study the neuroprotection of ghrelin in mice neurological disease model, but there is differences in this drug between human and rat, which one i should choose since both type of drug has been used in the published paper. Thanks.
Relevant answer
Answer
Both
  • asked a question related to Neurological Diseases
Question
7 answers
A patient with desminopathy survived Covid-19 six months ago without pneumonia, but with a temporary loss of smell and taste. After Covid-19, we note an accelerated progression of desminopathy, penetration accelerates, new muscles are quickly involved in the pathological process, muscle mass decreases, and heart function worsens. Perhaps the infection or its consequences are somehow connected with the mechanism of progression of desminopathy?
  • asked a question related to Neurological Diseases
Question
6 answers
To save life in desminopathy, can the body purposefully reduce muscle mass, for example, due to decreased heart function or for another reason?
It is known that when hypothermia, the body sacrifices limbs for survival. Is it possible with desminopathy a similar phenomenon?
Relevant answer
Answer
Dear Mozhgan Norouzi, thank you very much for your reply!
  • asked a question related to Neurological Diseases
Question
4 answers
Many published articles shows that some drugs have the neuroprotective effect on the neurological diseases. But when it comes to how it could reach the place where it exert its effect, it is unclear. So does it really have the neuroprotective effect or just meaningless results.
Relevant answer
Answer
Meaningless unless there is a result that requires the drug reaching the brain (or CNS), but still it is unclear whether it is the compound itself or a "derivative"
Worse: right now the FDA has not any protocol to assess (in humans) the efficacy of a drug as being neuroprotective
  • asked a question related to Neurological Diseases
Question
4 answers
I want to find the target receptor for a ligand ,whose effects can be beleived to vary in physiological system of underdeveloped or new born pupps than in adult dogs. How to find the function and mechanism of the same ligand in mice models ,for the treatment of neurological disorders in dogs.
Relevant answer
Answer
Hi Shruthi
I have in my past life heard/learnt at Vet school about dog condition similar to Duchenne muscular dystrophy reported in golden retrievers.
Duchenne muscular dystrophy (DMD) is neuro-muscular disease caused by a genetic problem in producing dystrophin, a protein that defends muscle fibers from breaking down when exposed to enzymes in muscles and particular regions of CNS. DMD occurs mostly in young males, though in rare cases may affect females. The symptoms of DMD include progressive weakness and atrophy of both skeletal and heart muscle. Respiratory insufficiency contributes to morbidity of muscular dystrophy and, along with cardiomyopathy. In dogs, condition was originally reported in golden retrievers and termed golden retriever muscular dystrophy (GRMD).
Here you can read PMID: 33071066 about study performed on young dogs
Here is more about the disease PMID: 11834588
You may decide after all reading to check GRMD more closely, if there are studies showing comparison of young pups vs. older and how they are neurologically examined by Vets in the clinic. Hope this helps
Filip
  • asked a question related to Neurological Diseases
Question
32 answers
Dear Colleagues, there is a 67 year old female patient with focal edema of frontal, parietal and temporal right side cerebral lobes, with slight dislocation of median brain structures on MRI, no enhancing contrast regions. Sick for 1,5 months, symptoms: fatigue, slight ataxia, slow thinking, no headache. Exam: slowliness of all types actions. No signs of compromised immunological status, no signs of infections. MRI performed twice: 25 september and 20 october, looks almost the same. Some ideas? thank you!
Relevant answer
Answer
Dear Dr Olga Schiopu,
I invite you to visite this link:
Best regards,
Pr Hambaba
  • asked a question related to Neurological Diseases
Question
4 answers
In a patient with hereditary desminopathy (mutation Thr341Pro DES in the heterozygous state) over the past three years, an increase in the blood uric acid level up to 440-480 µmol / l was established by 1.5 times (the norm is 428.4 µmol / l). With the progression of the disease, the level has risen and is above normal. It is known that uric acid is an antioxidant. Is it necessary to reduce the level of uric acid? The patient has no problems with the joints.
Relevant answer
Answer
The change in the level of uric acid and biochemical parameters in a patient with an identified case of desminopathy is presented in the article https://www.researchgate.net/publication/357311034_CHANGE_IN_REDOX_STATUS_AND_BIOCHEMICAL_PARAMETERS_IN_PATIENT_WITH_DESMINOPATHY_T341P_SEVERAL_YEARS_AFTER_DISEASE_SYMPTOMS_ONSET
  • asked a question related to Neurological Diseases
Question
20 answers
How Does COVID-19 Affect the Brain? Are there implications of COVID-19 in Neurological Disorders?
Relevant answer
Answer
Sure, COVID 19 can affect the brain. As we saw in our practice many patients with covid 19 had ischemic stroke, Encephalopathy. also I have 2 patients , the presenting features of coved 19 were Polymyositis, and 3 patients with GBS.
many individuals had post covid ischemic stroke
Thanks
  • asked a question related to Neurological Diseases
Question
289 answers
In the aftermath of the 1918 Spanish Flu pandemic there was a marked increase in incidence in psychological and psychiatric illness incidence. These conditions now often referred to generically as post-viral syndrome increased hospital admissions and treatment of mental health disorders in the years following the outbreak in 1918.
Population studies in countries that did not take part in World War One seem to indicate that the possible post war melancholy could be ruled out as a confounder as this increased incidence was seen in all countries affected by the flu that had been non-combattants in WW1.
Could there be a lasting and chronic element to all SARS type respiratory disorders?
SARS genome sequences have been detected in the brain of earlier SARS autopsies with LM, EM, and with real-time RT-PCR. The signals were confined to the cytoplasm of numerous neurons in the hypothalamus and cortex. Oedema and scattered red degeneration of the neurons was identified in the brains of 80% of the confirmed cases of SARS examined.
SARS viral sequences and pathologic changes have not been found in the brains of unconfirmed cases or control cases.
We may have a longer lasting health care problem that will affect those 'recovered' from Covid-19 for some years to come.
Relevant answer
Answer
Of course: YES !!. The Covid-19 coronavirus is neurotrophic, but -in addition- it is generating thousands of behavioral and psychopathological disorders due to the infinity of biopsychosocial problems that it is generating ... not to mention the so-called "pandemic fatigue" that the entire population is suffering. in general because of the "anti-Covid control" measures (confinements, border closures and perimeter closures of cities, time controls, curfews, etc.) that are influencing a lot and changing our lifestyles ... phobias are skyrocketing. , paranoid and catastrophic ideations, Post-Traumatic Stress Disorders -PTSD-, sleep problems and disorders, over-stress, anxiety, depression, pathological grief for the deceased, problems of schooling and socialization of children and a long etcetera (without going any further far, the Separations and Conflicts of Couple have increased in the West by 135%).
  • asked a question related to Neurological Diseases
Question
5 answers
Over the past three years, a patient with hereditary desminopathy (Thr341Pro DES mutation in the heterozygous state) has an uneven decrease in muscle strength in the hands. In the right hand, the decrease in muscular strength in the last three years is 2.1 times, and in the left one - 1.5 times. In a weaker limb, the disease progresses faster. A similar pattern is observed in the legs. The father of the patient had the same changes.
Relevant answer
  • asked a question related to Neurological Diseases
Question
5 answers
A patient with hereditary desminopathy (mutation Thr341Pro DES in a heterozygous state) with disease progression has a significant decrease in taste. How can this fact be explained?
Relevant answer
Answer
Probably affect facial nerve and glossopharyngeal nerve in the pons and medulla oblongata?
  • asked a question related to Neurological Diseases
Question
6 answers
In a patient with hereditary desminopathy (Thr341Pro DES mutation in a heterozygous state) with disease progression, a significant decrease in olfaction is noted. How can this fact be explained?
Relevant answer
Answer
I agree with Japneet Kaur. The problem in the cilia of olfactory sensory neurons. The myofibrilar myopathy is a genetic disease that associated with the primary ciliary dyskinesia. The primary ciliary dyskinesia resulted in defective cilia and olfactory receptors.
Attached, please find the article describing both myofibrilar myopathy and primary ciliary dyskinesia.
  • asked a question related to Neurological Diseases
Question
2 answers
Within three years, a patient with a desminopathy (Thr341Pro DES mutation) was found to have a 17% increase in the level of C4 complement components to 0.41 g / l (Norm 0.1-0.4 g / l).
Relevant answer
Answer
Dear Yosvany Castillo! Thank you very much for your answer. Over the past 2 years in this patient with desminopathy (Thr341Pro DES mutation in the heterozygous state), the C4 level of the complement component decreased to 0.36 g/l without taking medications.
  • asked a question related to Neurological Diseases
Question
3 answers
Immune system and Inflammation impact on the Gut-Brain axis !
The Gut/Immune/Nervous (GIN) communication
New insights into how immune system and inflammation play a role in Parkinson's Disease
Nov. 2019
New research indicates that the earliest stages of Parkinson's disease (PD) may occur in the gut with a likely relation to inflammatory bowel disease (IBD).
Parkinsonism is not just a brain disorder, but a group of diseases that may have their onset in the GIT. It is strongly suggested that individuals with an increased tendency for peripheral inflammation have a higher risk to acquire PD. Given the potentially critical role of gut pathology in the pathogenesis of PD, IBD may impact PD risk.
Peripheral immune system alterations may play a role in PD, which has the potential for new therapeutic strategies. Understanding and appreciating the importance of the so-called gut-brain axis, the connection between gut and the brain in PD, has grown rapidly in recent years.
The inflammatory processes have naturally led to discussion of an association between IBD and PD since the two share some basic characteristics. IBD is currently considered an inappropriate immune response to the microbiota in the intestines, characterized by chronic pro-inflammatory immune activity, a trait now also suggested to be a fundamental element of neurodegenerative disorders.
Highlighting the relevance of the immune system, large genome-wide association studies (GWAS) and pathway analyses identified 17 shared loci between PD and seven autoimmune diseases including celiac disease, rheumatoid arthritis (RA), type 1 diabetes, multiple sclerosis, psoriasis, ulcerative colitis and Crohn's disease.
Many epidemiological and genetic studies have found that there seems to be an increased risk of developing PD among people with IBD. The association between IBD and PD may simply be that IBD is just one type of intestinal inflammation, so it is not IBD specifically that increases the PD risk but perhaps intestinal or peripheral inflammation in a broader sense.
Inflammation of the gut is only one of many symptoms on the list of changes in the gut and is associated with neural structures in PD patients. Thus, IBD might be just one of many sources of intestinal inflammation.
While IBD patients are more likely to get PD, the risk is still very small. Yet, for a given IBD patient, the probability of not getting the diagnosis is 95%-97%.
Future pharmacological therapies aiming at slowing or stopping PD progression should not only target patients well into the course of the disease, but also be administered to patients in the very early phases of the disease or at risk for developing PD.
Clinicians should be aware of early Parkinsonian symptoms in IBD patients but also in patients with chronic inflammatory disorders.
A focus on the potential role of the immune system and of systemic inflammation these neurological diseases is encouraged.
A clear knowledge of the mechanisms implicated in Gut/Immune/Nervous communication could help improve the prognostic and therapeutic tools leading to better quality of life for patients, reducing the exacerbation of PD symptoms, and delaying the progression of the disease.
Parkinson's disease is a slowly progressive disorder that affects movement, muscle control and balance. It is the second most common age-related neurodegenerative disorder affecting about 3% of the population by the age of 65 and up to 5% of individuals over 85 years of age. During the 20th century, PD was thought to be primarily a brain disorder, however, research has shown that it may actually begin in the enteric nervous system, the part of the autonomic nervous system that controls the gastrointestinal organs.
Source: Brudek, T. et al. (2019) Inflammatory Bowel Diseases and Parkinson’s Disease. Journal of Parkinson's Disease. doi.org/10.3233/JPD-191729
Relevant answer
Answer
.
I suggest reading this article-
Dinan TG, Cryan JF.The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol Clin North Am. 2017 Mar;46(1):77-89. doi: 10.1016/j.gtc.2016.09.007. Epub 2017 Jan 4
  • asked a question related to Neurological Diseases
Question
12 answers
A patient with hereditary desminopathy (Thr341Pro DES mutation in a heterozygous state) was recommended to refuse toothpaste. He continued to brush his teeth twice a day with a toothbrush with only water. As a result, within one month we noted a significant increase in strength and muscle mass in this patient. The patient did not take any medications during this period. After 30 days, the muscle condition returned to its original level. How can this positive effect be explained?
Relevant answer
Answer
The toothpaste may affect gut microbiota balance of the digestive tract thus affecting natural PH levels. The triclosan is proving s extremely aggressive. https://stm.sciencemag.org/content/10/443/eaan4116
  • asked a question related to Neurological Diseases
Question
3 answers
In a patient with hereditary desminopathy (Thr341Pro DES mutation in the heterozygous state), a significant loss of muscle mass is observed after a night's sleep, with its replacement by adipose tissue. How to reduce muscle loss during sleep?
Relevant answer
Answer
Dear Ali Javadmanesh, Adrian Fierl, Abdulnabi Abdullamer Matruod, thank you very much for your answers!
  • asked a question related to Neurological Diseases
Question
16 answers
Food as a culprit in devolvement of neurologic diseases is not a novel concept, as there is a history of specific neurologic diseases that are caused by deficiencies in nutrition, namely lack of certain foods in human diet, like vitamins. There are also diseases caused by excess of some nutrients, and even vitamins. This review, however, is not about these well-known conditions. It is about potential indirect effect of what is considered a “healthy” balanced diet in development of neurologic diseases. We discuss what is known about gluten sensitivity and neurologic disorders, and we extrapolate that there might be a much wider array of intolerances-sensibilities which don’t have yet an objective marker. We also expanded on a hypothesis that maybe other neurologic disorder with immune mechanism like MS might be a target of immunological overload of other antigens apart from gluten.
Relevant answer
Answer
Please go through the following PDF attachments.
  • asked a question related to Neurological Diseases
Question
6 answers
Joint pain is a very common problem with many possible causes - but it's usually a result of injury or arthritis.
Due to the fact that anxiety can increase long term stress, the risk of of inflammation is high. I think This inflammation can cause pain and swelling in joints, affecting every day movements.
Relevant answer
Answer
Please take a look at the following PDF attachment.
  • asked a question related to Neurological Diseases
Question
4 answers
Mobility may be limited due to accident,any complications, neurological diseases and muscle diseases
Relevant answer
Answer
I think the answer depends upon couple of factors
1. What is the country of residence ? Developed world usually have many options and facilitate the persons with disability. In the low resourced countries a person on wheelchair and restricted mobility might not have many options.
2. Educational level : many professional field require manual work and extensive moving. This might not be feasible for a person on wheelchair. But certain professions do not require too much mobility and can be performed on desk or in front of a computer screen
3. Motivation and Medical Condition: Depending upon the medical diagnosis, the person might not be able to do a job that demands prolonged sitting
Having said this all, there are exceptional people on wheelchair with major disability who have followed their dreams successfully and did wonders. e.g. Athletes in para-Olympics, Stephen Hawking, Christopher Reeve ( Superman) and others
I wish you the best
  • asked a question related to Neurological Diseases
Question
4 answers
Neurological disorders in Pakistan 
Relevant answer
Answer
Please take a look at the following RG links and PDF attachments.
Thanks!
  • asked a question related to Neurological Diseases
Question
9 answers
I wish to look at gliosis in a dish, basically the neurons start becoming apoptotic and glial cells come to the rescue. But if I have a patient neurons, how do I mimic this event? Any idea what can be used a control?
Relevant answer
Answer
Dear Yojet,
As you have found, "gliosis" has a huge amount of background literature. Both the CNS axon regeneration field and the excitotoxicity/stroke field have used the neuron/astrocyte co-culture model in the past to try to understand the role of astrocytes in neuroprotection, so I suggest looking at some of the older literature in those fields.
One of the original culture models for excitotoxicity with which I am familiar was developed by Dennis W. Choi, and used cortical neurons & astrocytes in contact with each other (there are other models). More recent Transwell studies were used to try to understand the role of direct contact vs. secreted factors in toxicity and rescue, as well as the inhibition or promotion of axon outgrowth. I also suggest looking at publications from Ben Barres' lab regarding astrocyte function and neuronal survival.
Transwells are a great approach. However, one system used to culture primary neurons used feeder layers of glial cells, with the neurons cultured on glass coverslips that were inverted over the glia. Since the distance of the coverslips can be varied by the size of the paraffin dots that support the coverslips, if you are already culturing your neurons on glass, you might consider that method as a first approach. Details of that method can be found in the book Culturing Neuronal Cells that is edited by Banker & Goslin:
Good Luck!
Jill
  • asked a question related to Neurological Diseases
Question
6 answers
Hi,
I'm looking papers about diet intervention in patients suffering from Alzheimer disease. Have you seen any?
Thanks,
Mikołaj
Relevant answer
Answer
There is much less on diet and progression of AD than on diet and the onset of AD. However, here are a couple of recent articles that you may find interesting and
Regards,
Simon Young
  • asked a question related to Neurological Diseases
Question
7 answers
A patient with hereditary desminopathy (a mutation of Thr341Pro DES in a heterozygous state) with the progression of the disease has been established for a long-term healing of skin tissue when it is damaged, compared with a healthy person. The blood sugar level of a patient with desminopathy is normal.
Relevant answer
Answer
informative discussion.
  • asked a question related to Neurological Diseases
Question
2 answers
Stem cells treatment is effective in neuroscience and cells available from dental pulp may be used to treat neurological disease
Relevant answer
Answer
Hi Satish,
Perhaps, you can use some non-invasive biomarkers to understand like MRI etc.
Thanks
  • asked a question related to Neurological Diseases
Question
8 answers
I recently worked on a client/patient who had suffered for a week from a migraine. Massage therapy to the cervical soft tissues and suboccipital areas as well as to the masseter and facial areas did not resolve the pain.
Relevant answer
Answer
Life style changes are also important for migraine management
Nazari, F., Safavi, M., & Mahmudi, M. (2010). Migraine and its relation with lifestyle in women. Pain Practice, 10(3), 228-234.
  • asked a question related to Neurological Diseases
Question
11 answers
Over the past four years, in a patient with desminopathy (Thr341Pro DES mutation in the heterozygous state), the majority of antioxidant status indicators increased 1.2-2.0 times. Including glutathione in the blood increased 1.8 times to a value of 896 μmol / l (the norm of 500 - 1500 μmol / l), and the level of coenzyme Q10 in the blood increased 1.8 times to a value of 0.8 mg / l (norm 0,4 - 1,6 mg / l), vitamins E and C increased by 1.3 times, respectively, to 6.4 and 6.2 μg / ml.
In the literature there are conflicting data on their effect on the human body.
Relevant answer
Answer
Dear Muneeb and Anne, many thanks for your answers and recommendations.
  • asked a question related to Neurological Diseases
Question
7 answers
Over the past six months, a patient with hereditary desminopathy (Thr341Pro DES mutation in the heterozygous state) has a 1.6-fold increase in the level of the pro-inflammatory cytokine interleukin-6 to a value of 8.77 pg / ml (<7.00 pg / ml).
In addition, several parameters indicate the presence of inflammation: an increase in the number of immunity cells with markers CD25 +, CD95 +, HLA-DR + in the T-cell link; as well as an elevated level of C4 complement components.
The level of other cytokines Il-1β, Il-8, Il-10, TNF-α is normal. At the same time, the immunoregulatory index fell below the norm and is 1.19.
Details are indicated in the questions of this project "myofibrillar myopathy".
Dear scientists, please, join the discussion on this issue, do not limit yourself to viewing only. Ask me additional questions, send messages to your personal mail. Ready to answer any questions and listen to wishes.
Relevant answer
Answer
I am not very relative, but to the best of my knowledge IL-10 is the best antidote, similarly HemeOxygenase 1 can also be considered.
  • asked a question related to Neurological Diseases
Question
6 answers
Some rare references nowadays focus on autoimmune neurologic diseases triggered by some vaccines such as flu vaccine . I want to estimate incidence rate of this subject annually... Can anyone help me?
Relevant answer
Answer
Dear Ramin
There are some evidences of autoimmune reaction after vaccination, and some researches showed its possible role in initiating the autoimmune response. But based on the exact mechanisms and pathology of MS there is no any relationship and similarity between Flu virus antigens and Myelin Basic Protein as objective protein in MS! EBV and Clamydia infections are mostly possible involved agents in triggering the autoimmune reactivity in multiple sclerosis! Hope it contains some information.
  • asked a question related to Neurological Diseases
Question
17 answers
Question: Why are the results from science about treatment so difficult to implemented in therapy, especially by neurological diseases? Is that because there is still no integration between therapy and science ? And exist this barrier also because science don’t follow the patient in daily life and on the therapy ward! Or in other words to many investigation in the lab. and not in daily life situation. And is there an listening to each other? My experience is that many scientist do the story and leave and have not the time to listen to the stories of the floor !
Relevant answer
Answer
You may have a look to this Research topic in Frontiers
Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans?
Also, there are difficulties in assessing neuroprotection; I mean that it is not easy to get a drug approved for neuroprotection. Wich parameters you may meassure and are approvable by FDA for neuroprotection?
Last but not least there is lack of money for clinical trials to test promising drugs but whose patent has been already finished and are generic. We tried to implment a clinical trial with patients to test an "old" drug that is safe and with excellent results in animal models and wer unable to find money.
  • asked a question related to Neurological Diseases
Question
6 answers
I am planning to conduct a neurotoxicity assay using differentated neuro-2a cells. The protocol I am following recommends the use of poly-D lysine for cell attachment. However, we already have poly-L lysine in the laboratory. Will the use of poly-L lysine, instead of poly-D lysine, cause a huge difference in the differentiation, viability, and/or attachment of neuro-2a cells? Thank you very much.
Relevant answer
Answer
To help facilitate attachment, cell spreading, growth, morphology, differentiation PDL or PLL are used. In histochemical applications both polymers of D- and L-lysine are used to coat slides to promote attachment of cells. i use astrocytes cell for cell viability test in 96 wells. i found my cells are easily attached to the cell well without PDL or PLL coating.
  • asked a question related to Neurological Diseases
Question
2 answers
I'm looking to implant a cannula into lateral ventricles of 21-day old mice (13-16g). Does anyone have stereotaxic coordinates for mice this age/size?
Relevant answer
Answer
Go to: MBL weg servic, mouse atlases: mbl.org/mbt_main/atlas.html.
Making your own P21 mouse atlas in 10 steps. Succes. E.Marani
  • asked a question related to Neurological Diseases
Question
6 answers
C9orf72 is an expansion related to some neurological diseases such as ALS or dementia.
Relevant answer
Answer
Asuragen recenty launched a PCR based assay for C9orf72 amplification. You can find more information here: http://asuragen.com/portfolio/genetics/amplidex-pcrce-c9orf72/
  • asked a question related to Neurological Diseases
Question
13 answers
Hi. As we know by stimulating special cells, doctors and scientists are able to transfer different senses such as pain to patients. Now the question is: "Is it possible to import specific data such as words in other languages to brain by extracellular stimulation? "
Relevant answer
Answer
I am afraid that the question involves a confusion.  By stimulating certain areas of the brain you can give a subject a variety of experiences, including memory recall and pain.  But you are not transferring those experiences from anybody (or anywhere) else. You can also transfer genes into brains and give those brains new experiences.  For example, you can have mice experience colors that they could not experience before.  But I do not think it is possible to give some knowledge of specific words in a foreign language by transferring some cells.  First, being able to remember, understand, and use words involves many different and complex areas of the brain.  Such transplant would simply be impossible.  Second, even the attempt would be highly unethical since it would kill the donor.
  • asked a question related to Neurological Diseases
Question
1 answer
Currently, our team is working on mechanistic studies of two compounds which are acting in presence of a Biocatalyst having a particular residue highly important for carrying out reaction at room temperature.
After taking that residue (which is important for interaction) along with reactants, we are trying to find out the transistion state using QST2 method. we have already performed the optimization of reactants and the final product formed was obtained with Nimag value = 0.
While performing QST2 OPT+FREQ calculation it always gave an error how - Add virtual bond connecting atoms between atom a(assumption) and b(assumption).
termination is by LNKE error...
Relevant answer
Answer
Dear Tanuj,
It sounds that you should include two dummy atoms with a certain distance and connect them.
Rafik
  • asked a question related to Neurological Diseases
Question
4 answers
Hello,
For my research, people with Parkinson's disease need to perform a computer based cognitive task. I am looking for 
a) simple vision screening questionnaire
b) suggestions for exclusion criteria for IRB purposes.
Relevant answer
Answer
For vision screening, it is usually done via a task more than a questionnaire, it is called visual search task, a simple task that is enough for visual screening, these 2 links are helpful:
  • asked a question related to Neurological Diseases
Question
6 answers
If there is any research about diabetic neuropathy, please share the information here. I really need it for my research. Thanks in advance.
Relevant answer
Answer
To my knowledge, there is no link between diabetic neuropathy and central pain syndrome. Any patient with diabetes mellitus may, however, develop the central pain syndrome.
  • asked a question related to Neurological Diseases
Question
7 answers
Antiinflammatory or morphine ?
Relevant answer
Answer
I have now an patient with an toral feotal attitude . The only respons is the push away othese that gives an decrease on tone in the whole body, She is lying on an firm matras with het best side to the wall.
When she lioes in this orthese she looks angry and push with there feet the orthesis away but when this movement occur the re face is ligthing and the tone decrease and here cognition is increase. No medication was given 
In this case there was the feeling of instabvility and that is no poain but fear !! 
  • asked a question related to Neurological Diseases
Question
4 answers
I want to understand how quantum entanglement effects the neurons and the possible relationship between this and certain neurological disorders.
Relevant answer
Answer
It is too difficult for me to understand, but I liked the quote that Quantum.Fisher starts with, "“I can calculate the motion of heavenly bodies, but not the
madness of men” - Isaac Newton".  
Also, this author states that there is just one possible molecule involved "m processing - a neural qubit - while the phosphate ion is the only possible qubit-transporter" and further down states that some measurements might be repeated. Sounds like the theory might easily be falsified.
If so, and it would take a physicist to convince me, I would pay taxes to help him or her falsify because I am a bit shocked that so much seems not well understood.  I do not believe what I do not understand, but... I can imagine that someone would falsify whatever far fetched idea there is, and at low cost.
  • asked a question related to Neurological Diseases
Question
3 answers
There were complications e.g. hemiplegi
Relevant answer
Answer
Hi Abdulhafeez,
Try to answer your question.. this patient is 13 old year boy, come with decreased of consciousness... No sign of immunocompromised before. he is totally well before this episode of encephalitis. CSF analysis is consistent with bacterial infection, and CSF culture yield bacillus cereus. This patient has a history of having porridge as a meal after swimming, then he got vomiting about 3 hours thereafter, followed by little bit fever. fever and vomiting continues for the next 2 or 3 days. After that, he got decreased of consciousness and admitted to hospital.
we conclude that bacillus cereus could be a significant pathogen in this case as he has a history of taking porridge (grain is commonly contaminated with this bacteria), has a history of vomiting and fever, then loss of consciousness. Analysis of CSF was also consistent with bacterial infection..
 so... what is your opinion? 
  • asked a question related to Neurological Diseases
Question
5 answers
In my experience, I observe that some patients cannot cough willingly, whereas the request is understood and the cough reflex is effective. Could I call this "cough apraxia" ?
Is it the same altered brain pattern that in bucco-facial apraxia ?
Relevant answer
Answer
Hi Emmanuelle,
In my past research, I assessed both voluntary and reflex cough in acute stroke survivors (reflex cough induced through inhalation of nebulised capsaicin). In my group of participants there were also some who were unable to cough voluntarily, although they triggered a reflex cough with capsaicin.
As a point of interest, as the investigator instructing the person to cough, I found that demonstrating a 'theatrical' cough myself (i.e. exaggerating my body language, and bringing my hand/fist to my mouth as I coughed - as some people would do naturally) helped to support my verbal instructions, and perhaps eliminated an element of receptive dysphasia for some stroke survivors. For individuals who had difficulty performing a voluntary cough, I found that it sometimes also helped to prompt them to use their hand, as if they were covering their cough with an open hand or fist; or to prompt them to cough into a tissue - I suspect that this taps into a 'natural' movement pattern that supports the execution of a voluntary cough for someone with cough apraxia.
With respect to the term 'cough apraxia', I have not come across the term very often. Studies tend to describe the inability to execute a voluntary cough as one of a range of characteristics of bucco-facial apraxia or oral apraxia - as Jordi describes above -, and the ability to perform a voluntary cough is often part of testing for bucco-facial/oral apraxia. A cursory literature search for 'cough apraxia' will yield a number of case reports and case series from as far back as the 1960s, where inability to cough voluntarily has been observed and documented.
Carol Smith Hammond uses the term 'cough apraxia' in her review article from 2008 (doi: 10.1007/s00408-007-9064-4), and Stephanie Daniels and colleagues discuss 'apraxic cough' versus weak cough in their more recent publication from 2015 (doi: 10.1007/s00455-015-9638-x).
To my knowledge, there has not been much work investigating the neurophysiology of specifically cough apraxia - With increasing interest in neurogenic cough impairment, this could make for an interesting study.
  • asked a question related to Neurological Diseases
Question
9 answers
I have visited an 29-year old man from Mali with signs of lower motoneurons (bulbar, upper limbs), resembling ALS. He travelled for 8 months from Mali to Italy in extremely hard conditions. Does someone know whether there are some toxic or infectious agents that can mimic ALS?
Thank You
Relevant answer
Answer
I can suggest the cases of spastic paraparesis related to "tropical spastic paraparesis and human T lymphotropic virus I-associated myelopathy" and the rare instances of Chronic Neuroborelliosis mimicking ALS (Wien med. Wschr. 27: 1995: 186-188).
Best,
Marco Poloni
  • asked a question related to Neurological Diseases
Question
4 answers
Nowadays, most of oral drugs available for the treatment of epileptic seizures are anticonvulsants. However, most of temporal lobe epilepsy (TLE) seizures do not manifest in convulsions. I heard something about a new therapy with antiepilergic drugs that aims to modulate the neurotransmitter function (i.e., GABA) but I do not know the effectivity of this last.
I would like to ask the expert community about the new approximations to this complex disorder (benefits/side-effects) and more specifically if you recommend to try another pharmacological treatment different from antiepilergic drugs in the case of TLE.
Thanks in advance,
Relevant answer
Answer
TLE is not a monolithic, homogenous entity. Seizures originating from the temporal lobe could be due to a calcified temporal lobe lesion, a focal cortical dysplasia, a gliotic scar, post encephalitic etiology (HSE), MTS etc. Not all seizures arising from the temporal lobe are difficult to control with anti seizure medication. In my experience, few patients do well on CBZ monotherapy or in combination with Clobazam.
  • asked a question related to Neurological Diseases
Question
5 answers
Good day all , I am planning to do an intensive program for diplegic cerebral palsy children , and I am looking for a good assessment tool to measure their improvement before and after the therapy , can anyone give me an advice of which assessment is the best in this case ?
  • asked a question related to Neurological Diseases
Question
2 answers
In many cases, neurological score and infarct volumes of MCAo/reperfusion (M/R) induced brain damage correlates. I mean if infarct volume is improved so does the neurological functions. However, sometime I experienced that there is no change in the infarct volumes but the neurological deficit is improved after drug treatment in M/R mice. For the confirmation I repeated the experiment but get the same results. I am using modified neurological severity score (mNSS) that is 18 point scaling for neurological deficit evaluation. To strengthen my findings, I need some published proof. Could you please help me? I have got 1 paper (but low impact journal) and need few more.
Relevant answer
Answer
Several answers:
1. Clinical mismatch between radiology and clinical impairment scores is well described, e.g. see Ebinger et al. Stroke. 2009;40:2572-2574.
2. Not all experimental interventions will be 'neuroprotective', i.e. reduce brain damage. Some will enhance recovery (i.e. plasticity rather than changing cell number), lead to regeneration (increase new cells) etc.
  • asked a question related to Neurological Diseases
Question
6 answers
Hello, dear neuroscientists.
I have several patients with severe epileptic syndrome, who suffer from often condition of Status Epilepticus. It is noticed that after hard seizures and returning from Emergency these poor children express exponential growth in cognitive development: they begin to use new words, new types of lexical structures, they sing new songs and declare new poems.
It's very strange for me, but I saw this by my own eyes. How it can be?
Relevant answer
Answer
It will be nice if you can share some anonymous stories if possible.
  • asked a question related to Neurological Diseases
Question
15 answers
It is said nowadays that MS might be a neurodegenerative disease but the question is if  it so then what are the differences between MS with other neurodegenerative diseases eg, Alzheimers disease or Perkinson disease?
Thanks in advance,..
Relevant answer
Answer
Wrong question: MS is not a neurodegenerative Disease. A meaningful question could be: what have MS and neurodegenerative diseases in common?
  • asked a question related to Neurological Diseases
Question
3 answers
Can stem cell implants help schizoaffective disorder?  If so, what is the closest location to Richmond, Virginia?
Relevant answer
Answer
There was one study published a couple of years ago from Mount Sinai in Newyork, elaborating on possible course modelling & disease modification via stem cells for schizophrenic patients. 
  • asked a question related to Neurological Diseases
Question
4 answers
I am writing a review article on treatments for cerebral palsy (which I have actually got). I am having great troubles finding clinical trials of controlled studies which have investigated spasticity or other measures of disability in cerebral palsy for many drugs. This hasreally surprised me because I have been prescribed tizanidine in the past and I currently take clonazepam.
There is a lot of research that has investigated the effectiveness of tizanidine, clonazepam, dantrolene and tiagabine on spasticity in people with multiple sclerosis, spinal cord injury and post stroke spasticity, but not CP. This is a bit troubling because cerebral palsy affects a different area of the brain and different neurological/chemical pathways and I am really surprised that other review articles have recommended them but not shown any evidence of their effectiveness in CP (see attached).
Any help would be greatly appreciated.
Relevant answer
Answer
Hi,
Yeah, I have found a lot of reviews for baclofen and some for other GABAa and GABAb agonists/allosteric modulators. However, I am really bemused how reviews are suggesting certain pharmaceutical agents when there is no evidence of their effectiveness on the symptoms of CP in humans.
The other thing which I am finding quite frustrating is that nearly all the controlled trials focus on spasticity and not on ataxia. I understand that spasticity is very important when people are getting dressed or transferring from one seat to another but the ataxia is equally as difficult to cope with for the patient and their carers. I know that some tests touch on this, such as the PEDI and the GMFM but none of the drugs actually target the ataxia specifically and I really do not see why.
Does anyone have any ideas?
  • asked a question related to Neurological Diseases
Question
6 answers
I am curious about this research.
Relevant answer
Answer
The study referenced below doesn't directly address the issue, but suggests that the so-called "delusions" of dementia are related to memory issues and can be related to reality whereas psychotic delusions cannot. It may at least give you some literature to help you formulate the question:
The meanings of delusions in dementia: A preliminary study.
By Cohen-Mansfield, Jiska; Golander, Hava; Ben-Israel, Joshua; Garfinkel, Doron
Psychiatry Research, Vol 189(1), Aug 30 , 2011, 97-104.
One of the common symptoms of dementia is delusions. Due to a biological conceptualization of the behaviors represented as delusions, these are classified as psychotic symptoms. This is a qualitative and quantitative study aiming to describe the delusions experienced by older persons with dementia and the context of occurrence, and to elucidate their etiology. Participants were 74 nursing home residents aged 65 and over, diagnosed with dementia, from nine nursing homes in Israel. Participants with delusions were found to have significantly more difficulties in performing ADLs, and poorer vision and hearing. Based on assessment using the BEHAVE-AD, six categories of delusions were examined: 1. One's house is not one's home, 2. Theft, 3. Danger, 4. Abandonment, 5. Misidentification, and 6. Other non-paranoid. Common themes appeared across delusions including reality, disorientation, re-experience of past events, loneliness and insecurity, boredom, and trigger. Current results suggest that delusions may not represent psychotic symptoms for most participants, because they sometimes represented reality, or were neither firm nor incontrovertible. Thus, utilizing the term delusion relegates the person's behavior to the domain of severe psychiatric phenomena and precludes understanding its true meaning. (PsycINFO Database Record (c) 2014 APA, all rights reserved)
Another study hints at some similar issues:
Les relations entre mémoire autobiographique et self dans la schizophrénie: L’hypothèse d’une dysconnexion. / The relationships between autobiographical memory and the self in schizophrenia: The dysconnexion hypothesis.
By Berna, Fabrice; Potheegadoo, Jevita; Danion, Jean-Marie
Revue de Neuropsychologie, Neurosciences Cognitives et Cliniques, Vol 6(4), Oct-Dec 2014, 267-275.
Schizophrenia is a mental illness known to be associated with severe disorders of self. It is also characterized by cognitive impairment, which affects, in particular, executive functions and autobiographical memory. Our research work was based on the theoretical model put forward by Conway (2005), which posits reciprocal relationships between autobiographical memory and the self. Our results led us to the hypothesis of a dysconnexion between the self and autobiographical memories in schizophrenia. This dysconnexion would be the consequence of altered executive processes linked to the self, this affecting the balance between cognitive and affective processes. This dysconnexion may account for a global weakening of the phenomenological characteristics of autobiographical memories, a poorer integration of the memories, which are closely linked to the self, a deficient organization of autobiographical memory and the development and maintenance of persecutory delusions. These results led us to develop several therapeutic interventions, such as cognitive remediation methods aiming to reinforce the subjective experience associated with the recall of past events and psychotherapeutic programs aiming to reinforce the links between past personal events and the self. (PsycINFO Database Record (c) 2015 APA, all rights reserved)
  • asked a question related to Neurological Diseases
Question
3 answers
Most of the papers suggest to use MPTP conc ranging from 40 ug/mL to 200 ug/mL. However, in my case, all the larvae (4 dpf) die after 24 hrs exposed to the MPTP (1 mM), same result goes to the concentration at 30, 40, 50 ug/mL after 24 hrs of exposure. Initially we were thought that our MPTP stock was expired, but we got the same result of the newly purchased MPTP. We prepared the MPTP stock (10 mg/mL) in water and stored the aliquo MPTP in the final concentration of 1 mg/mL at -20. I would be very grateful if anyone could give some advises/suggestions to me on how to treat larvae.
Many thanks in advance
Relevant answer
Answer
Hi, but non of the publication did the acidic test.. if it is too acidic, mean we need to adjust the ph by adding NaOH? will it affect the fish?
  • asked a question related to Neurological Diseases
Question
7 answers
Does anyone have experience with SaeboFlex in neurological hand treatment?
Relevant answer
Answer
Super! Thank You.
  • asked a question related to Neurological Diseases
Question
4 answers
these widenings are causing due to tension and overthinking, Initially it started with tremors, in later stages it giving just pain and swelling in head. Only this information was provided by Doctor.
Relevant answer
Answer
Thinking does not structurally harm the brain. Folia exist anatomically in the cerebellum, but relations to cognitive problems are rare. Unfortunately, the question is not precise enough to advice further in this context.
  • asked a question related to Neurological Diseases
Question
5 answers
What are the recent guidelines and advancement in the PD management? Please share your experiences.
Relevant answer
Answer
Resveratrol Stabilizes Amyloid in Alzheimer's
Pauline Anderson
| September 17, 2015  
9 comments
Print
Email
 
Editors' Recommendations
Oral Resveratrol Stabilizes Amyloid in Alzheimer's
Resveratrol Does Not Reduce CVD Risk, Prolong Life
Alzheimer's Disease News & Perspectives
My Alerts
You have already selected "Alzheimer's Disease" for My Alerts
 
 
High doses of purified resveratrol, a polyphenol found in some foods, appear to stabilize levels of amyloid beta (Aβ) in cerebrovascular fluid (CSF) and in plasma in patients with mild to moderate Alzheimer disease (AD) and are safe and well tolerated, a new phase 2 study has shown.
Although it is too soon to start recommending resveratrol supplements to patients, the research indicates that this compound is safe and is promising, lead author R. Scott Turner, MD, PhD, professor, Neurology, and director of the Memory Disorders Program, Georgetown University Medical Center, Washington, DC, one of 21 medical centers across the United States participating in the study.
"It seems to have some interesting effects, enough to justify further research into this strategy," he told Medscape Medical News.
The study was published online September 11 as an Open Access article in Neurology.
  • asked a question related to Neurological Diseases
Question
3 answers
Techniques to validate a protocol in home and health care, like image exams with low resources.
Relevant answer
Answer
Hi Priscila maybe you can get someaditional information in Home Healthcare Nurse:
April 2008 - Volume 26 - Issue 4 - p 244–250 doi: 10.1097/01.NHH.0000316703.22633.79
INTERDISCIPLINARY Team Perspective
bw
  • asked a question related to Neurological Diseases
Question
3 answers
My colleague and I discussed about the following three patients with early onset of Parkinson's disease. 
Case 1 carries  p.A340T & p.N521T of PINK1 gene, both of which variants are not pathogenic  according to PDmutDB. Therein, this case does not carry PINK1 gene mutation. 
Case 2 carries p.A206T & p.V380L of Parkin gene. p.V380L of Parkin gene is not pathogenic, although function of Parkin p.A206T is unknown. So, case 2 is not a compound heterozygous Parkin mutation carrier. 
Case 3 carries p.S167N & p.R366W of Parkin gene. p.S167N of Parkin gene variant is not pathogenic, although p.R366W is pathogenic according to PDmutDB. Therein, case 3 is not a compound heterozygous Parkin mutation carrier. 
What would you think? Thanks.
Yue
Relevant answer
Answer
Sorry, let me rephrase the last sentence.
Would you think the conclusive statements about Parkin or PINK1 gene status of these three patients are right? 
  • asked a question related to Neurological Diseases
Question
2 answers
I have patients with this strange phenomenon who do not have nystagmus or peripheral cerebellar signs.
Relevant answer
Answer
In children usually central cerebellar lesions result in bad gait dysfunction & trunkal ataxia. We have seen this with tumors & more strangely with post-viral cerebellitis as well. The more peripheral the lesion extends, the more chance it interfere with 4th cranial nerve nucleus pathway, that is why we see nystagmus, dizziness or autonomic manifestaions with over-whelming inflammatory conditions, which tend occasionally to spare the vermis.
  • asked a question related to Neurological Diseases
Question
7 answers
Can anybody tell me what is usual trend of the EEG segment duration used in feature extraction to process for real-time seizure detection?
Relevant answer
Answer
Usually one second epochs are used in seizure detection.There are papers with 2 sec and 3 sec also.
  • asked a question related to Neurological Diseases
Question
4 answers
Very interestingly, we have come across a high titre of the CMV & HSV in the blood report of a 31 year old legally Blind female, that has been blind for 4 years.
Upon infusing respective antiviral, patient was able to see clearly most of the colors. Has anybody out there studied the Neuro Invasive viral impact on the visual cortex? 
Relevant answer
I advise you to find experts at the Vienna Medical University - special institute of Ophthalmic immunology and virology.
Good luck!
  • asked a question related to Neurological Diseases
Question
5 answers
I want to compare cytokine levels between a neonatal and adult mouse brain post infection. 
Relevant answer
Answer
 Can you send me the protocol for Mesoscale James. My email id is ganesanp@duq.edu
  • asked a question related to Neurological Diseases
Question
12 answers
Im trying to conduct a neuroprotective assay with SH-SY5Y cells differentiated with RA and TPA to dopaminergic neurons. 
There seem to be multiple cell lines capable of similar feats, and some that seem to be used more without differentiation.
Is there any reason to go through the trouble of dual differentiation? or would it be easier and more reliable/reproducible to work with N2A/CATHa/PC12 cell lines, as they seem to be the standard in neuroprotective research. 
I understand that SH-SY5Y cells are of human origin, but even still, they dont seem to be heavily used when compared to mouse line.
Relevant answer
Answer
Hi Kelly,
In our lab we are using SH-SY5Y cells for PD research. N27 rat dopaminergic cell line is another choice of ours. However, I think, one of the best options you can use is the primary midbrain cultures isolated from rat embryos. We dissect midbrain from E17 rat embryos and culture the cells. It's, obviously, a mixed culture including dopaminergic and GABAergic neurons, as well as astrocytes and microglia. You can also inhibit the growth of glial cells in cultures dishes via different treatments if you wanna eliminate these. Since it's a mixed culture, you can see the effect of your treatment/chemical/compound on different neuronal or glial cells, which might be an advantages depending on the purpose of your neuroprotective assay.
I hope this helps a bit. Good luck!
  • asked a question related to Neurological Diseases
Question
6 answers
I see children who have ADHD, LD, or Autism Spectrum disorders, I usually share neurodevelopmental perspectives with parents. An 8 year old male, with early ADHD, now 8, diagnosed 2/15 with aggressive melanotic medulloblastoma,  metatstatic drops on the spine. 98% tumor removal by surgery. Any thoughts or research about embryonic factors that may suggest correlation of these two conditions?
Relevant answer
Answer
Thank you for the response, and the sharing of your professional experience
  • asked a question related to Neurological Diseases
Question
3 answers
Thank you.
Relevant answer
Dear Mahdieh Golzarand,
Check this out:  
Dissociable Neural Responses in Human Reward Systems
Rebecca Elliott, Karl J. Friston, and
Raymond J. Dolan
The Journal of Neuroscience, 15 August 2000, 20(16): 6159-6165;
From the abstract:
.....functional neuroimaging was used to assess neural response within human reward systems under different psychological contexts. Nine healthy volunteers were scanned using functional magnetic resonance imaging during the performance of a gambling task with financial rewards and penalties. We demonstrated neural sensitivity of midbrain and ventral striatal regions to financial rewards and hippocampal sensitivity to financial penalties. Furthermore, we show that neural responses in globus pallidus, thalamus, and subgenual cingulate were specific to high reward levels occurring in the context of increasing reward. Responses to both reward level in the context of increasing reward and penalty level in the context of increasing penalty were seen in caudate, insula, and ventral prefrontal cortex.
  • asked a question related to Neurological Diseases
Question
1 answer
I'm trying to load an AM-ester dye in an acute hippocampal brain slice. I am specifically interested in microglia (which are GFP labelled), however, I understand that microglia are particularly difficult to image with these dyes. 
We recover for 1 hour in aCSF at room temperature after slicing, then I will incubate with the dye (containing DMSO and diluted in aCSF) at room temperature for 30 min. 
Does anyone have tips for getting AM-ester dyes into microglia?
Thanks!
Relevant answer
Answer
This RP might lead you to the exactly needed references. 
The use of calcium-dependent fluorescent indicator dyes has enabled the measurement of synchronized activity across a network of cells. This technique gives both high spatial resolution and sufficient temporal sampling to record spontaneous activity of the developing network.
J Vis Exp. 2011; (56): 3550.
Published online 2011 Oct 22. doi: 10.3791/3550
PMCID: PMC3227196
Functional Calcium Imaging in Developing Cortical Networks
Julia Dawitz et al
  • asked a question related to Neurological Diseases
Question
5 answers
Hello, I'm currently writing a literature based dissertation project about Amyotrophic Lateral Sclerosis and therapeutic drugs required for its treatment. Therefore I was hoping if there would be any clinical trial data information available..? Thanks
Relevant answer
Answer
see the paper by virginia le Verche , B Ikiz, A Jacquier, S. Przedborski and D B Re 
J receptor, ligand and channel Research 
4, 2011, 1-22. Glutamate pathway implication in amyotrophic lateral sclerosis: what is the signal in the noise ?
  • asked a question related to Neurological Diseases
Question
2 answers
Kindly I need a database (raw data or data-set) for Sagittal kinematic data and kinetic data for children with cerebral palsy. and the type of their gaits (crouch gait, jump gait, apparent equinus, true equinus and mild gait).
Relevant answer
Answer
You will find the data set of CP children with crouch gait used in the paper of Steele K. et al., "Muscle contributions to vertical and fore-aft accelerations are altered in subjects with crouch gait", in the following link: https://simtk.org/home/ crouchgait
Sincerely,
Emiliano Ravera
  • asked a question related to Neurological Diseases
Question
6 answers
recurrent episode of left arm weakness, slurred speech positive pronator drift, lasting < I minute. MRI brain normal, EEG mild right hemisphere slow, during the episode.
even though, they discharge him as TIA, not seizure!
Relevant answer
Answer
I still think this is migraine. But once that's said, there still is a differential diagnostic list of syndromes that are associated with recurrent, "plegic" (as in hemiplegic or diplegic or...) migraine. For some reason, in the back of my mind, there's pointer to a variety of disorders lumped together as the dysautonomias - including Riley-Day,
  • asked a question related to Neurological Diseases
Question
1 answer
Hello, I am interested about some genetic tests. I have 2( female) interesting neuromuscular cases, one with Charcot Marie Tooth and Steinert Miotonia, 38 years old, and other with neuromiotonia, axonal cronic neuropathy and sick sinus syndrome -maybe an interesting association of Chanelopathies, aged 31.
I would like to present this cases but I need collaboration with colleagues specialized in this field!
Sincerely yours,
Adella
Relevant answer
Answer
If you have genetic confirmation of both a CMTD and myotonic dystrophy, that's a pretty unique case!  The neuropathy with myotonia and sick sinus sounds like a very rare bird as well. You would want the DMPK repeat testing, ZNF9 repeat testing if older onset, CLCN1 and SCN4,  and maybe a good CMTD panel like the one from Invitae for these, unless some of the clinical and eleectrodiagnostic features and family history would narrow it down more.  Athena offers a myotonia panel but it is very expensive so that would be good if you can.
  • asked a question related to Neurological Diseases
Question
6 answers
i am looking for research materials on the effects of air freshener substances on the brain, i have seen some materials but they are not scientifically backed. i know some of the substances causes toxic encephalopathy, dementia and other neurological diseases but i need their scientific basis
Relevant answer
Answer
Hi, Air fresheners can include fragrances, aerosol propellants, and solvents. As fragrances, air freshener preparations often include terpenes such as limonene. Also, many air freshener products emit allergens and toxic air pollutants including benzene, formaldehyde, terpenes, styrene, phthalate esters, and toluene, plus formaldehyde, hydroxyl radical, and secondary ultrafine particles. Defining the substances will be importanto to find the references. We have some studies on the effects of solvents such as toluene in humans and animal models. One has also to consider the dose that you want to refer to- are you looking at the abusive use of air freshners or the most common and thought way of using it in domestic setting?
  • asked a question related to Neurological Diseases
Question
6 answers
There is always cost to interrupting the normal function of the body.  What are the consequences of manipulating the neuro system in delaying dementia?
Relevant answer
Answer
At least one study has shown that higher cumulative anticholinergic use is associated with an increased risk for dementia.
see Gray et al., 2015
  • asked a question related to Neurological Diseases
Question
13 answers
As part of an ongoing project with ICHOM to develop a global set of outcomes for people with dementia we are interested in hearing about disease specific registries and the outcomes that are used by these projects.
Relevant answer
Answer
There are registries for AD and related disorders. Some of them are as follows:
1. Alzheimer's Disease Registry from The Office for the Study of Aging (OSA) http://www.sph.sc.edu/osa/alzheimers_registry.html
2. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) http://cerad.mc.duke.edu/
3. Alzheimer Prevention Registry (http://www.endalznow.org/)
4. St. Louis Alzheimer’s Association Research Registry (http://www.alz.org/stl/in_my_community_14848.asp)
5. Wisconsin Registry for Alzheimer's Prevention (WRAP) (http://www.wai.wisc.edu/research/wrap.html)
  • asked a question related to Neurological Diseases
Question
1 answer
I'm looking for MPNST cell lines that are strictly from sporadic (non NF associated) MPNSTs to compare to NF associated MPNST. I know of STS-26T and HS-Sch-2, but do others exist? There seem to be very few. <br />
Relevant answer
Answer
Non NF associated MPNST do exist but the lifetime risk of having only MPNST  have a 0.001% chances in the general population....
ST88-14, and NF90-8 are the other cell lines on which you will find few work done...
Find the attached articles to know more..
Hope it will be helpful...
All the best
  • asked a question related to Neurological Diseases
Question
5 answers
A syndrome of keratosis palmo-plantaris congenita, pes planus, onychogryphosis, painless trophic ulcer, clubbing of fingers, periodontosis, arachnodactyly and a peculiar acro-osteolysis has been reported.
Relevant answer
Answer
Dear Americo I have seen only one case referred  from Pediatric Dep. The case published at :
Sudanese Journal of dermatology
Postal Address : P.O.Box:10486. Khartoum 11111, Sudan.
Telephone : + 249 12350864
Web Site: www.ajol.info
Bashir, A.H.H. Acrodystrophic neuropathy of Bureau and Barriere in Sudanese patient - Single case report & Review. Sudan J Dermatol 2006; Vol 4 (2): 74 – 80.
  • asked a question related to Neurological Diseases
Question
10 answers
Why does Huntington's Disease (HD) affect the brain while Huntington protein (Htt) is expressed in every tissue of the body? Secondly, does the CAG trinucleotide expansion mutation in HD gene (HTT) occurs only in the brain?
Relevant answer
Answer
HTT is ubiquitously expressed and over the past decade it has become apparent that  patients with HD experience a wide array of peripheral organ dysfunction including, weight loss, HD-related cardiomyopathy, skeletal muscle wasting and severe metabolic phenotype. (e.g. Front Physiol. 2014 Oct 6;5:380. doi: 10.3389/fphys.2014.00380. eCollection 2014; Lancet Neurol. 2009 Aug;8(8):765-74. doi: 10.1016/S1474-4422(09)70178-4; Neurology. 2008 Nov 4;71(19):1506-13. doi: 10.1212/01.wnl.0000334276.09729.0e. and others)
  • asked a question related to Neurological Diseases
Question
7 answers
After inducing seizures in the two sexes of mice there is a much higher rate in which males have seizures. I cannot figure this out. Please help!
Relevant answer
Answer
Hello Aaron,   
          A similar trend seems to exist in autistic spectrum disorders where the prevalence  in males is 4-5 times more than females. Disturbances in oxytocin levels are commonly implicated in autistic spectrum disorders and therefore increased levels of oxytocin in females is thought to be protective against developing autism spectrum disorders. This could be the case with epilepsy as well. Infact, epilepsy seems to be quite common in people with autistic spectrum disorders. In the hippocampus, oxytocin can enhance inhibition through its action on interneurons. Thinking on this line, difference in oxytocin levels could be one of the reasons for your observations.
Deepak.
  • asked a question related to Neurological Diseases
Question
2 answers
What method of activity monitoring, specifically heart rate intensity and activity duration, have been used to monitor exercise in PD?  We are interested in being able to confirm that individuals are exercising at a given percentage of their HR max, and over a specific duration of time...but also want to limit the amount of "interaction" the exerciser needs to have with the monitoring device (number of buttons to push, devices to put on/take off, etc..).  We are trying to move towards a more pragmatic method of monitoring - least invasive and least amount of "in-clinic" visits required for downloading of data.  We would also like to include as many individuals as possible and therefore are also trying to be conscious of the fact that many folks won't or don't have access to a smart phone, computer, or wireless internet access.  We are interested to hear what others have found feasible yet also reliable.
Relevant answer
Answer
Vera, thanks for sharing.  While such measures are helpful for "onsite" monitoring, we are interested in off-site monitoring.  We would like to be able to report on the intensity, frequency, and duration of activity done at home, which would enable us to report on adherence to protocol, etc...We would like to limit the number of clinic visits for data downloading, trying to keep to a more "real-life" scenario. We are presently looking into a wrist monitor that will give heart rate and time (without a chest strap), but haven't been able to find anyone who has used such a device for research purposes.
  • asked a question related to Neurological Diseases
Question
3 answers
No biological marker has been found in opsoclonus-ataxia syndrome.
It is supposed to be of autoimmune origin, but exact mechanisms remain obscure.
I would like to know more about theories and recent evidence on the topic.
Relevant answer
Answer
Thank you. I also think that autoantibodies are the main goal for research in Kinsbourne cases. In my experience, symptoms improvement with immunoglobulins is remarkable
  • asked a question related to Neurological Diseases
Question
14 answers
A 19 years old male patient feels muscle function loss on the right side accompanied by parasthesia to the right of the mandibula, which occurs for approximately 20 seconds. It relapses many times a day. In addition there is alveolar bone loss without tooth mobility and bleeding.
Relevant answer
Answer
This patient need to scanned for any Infra temporal Fossa lumps that can affect the main trunk of mandibular division containing  both sensory and motor fibres. I also seen a lady with same manifestation turned to have a nasopharyngeal Carcinoma.so do not lgnor these possibilities 
  • asked a question related to Neurological Diseases
Question
4 answers
Experiments on rats has yielded an optimal dosage to treat induced cerebellar ataxia. But can this dosage be scaled up to humans for this purpose?
Relevant answer
Answer
Interesting approach. Do you have any data apart from single cases on its efficacy? What dosage would be considered appropriate in humans?
  • asked a question related to Neurological Diseases
Question
4 answers
Some say it has no effect on non-motor symptoms (NMS); some say it does not always control tremor or bradykinesia very well.
In my (possibly atypical) case it has absolutely no effect on motor symptoms or NMS. But, if I reduce from one 100mg tablet 4 x daily to one tablet 3 x daily, after-3 days I become socially withdrawn. I recover completely within an hour of taking an extra tablet. I have searched the web for information and found… nothing.
Relevant answer
Answer
Hi Stephen- my main area of interest is in Orthopaedics but have a personal interest in Parkinsons. I also suspect that there are many atypical presentations of the disease- but since these have such variation in presenting symptoms and response to treatment, that it may be where your research would contribute. The main focus of research/ literature is on the treatment -cause & effect & in particular decreasing response and side-effects. It would be interesting to see what other quality of life issues occur but not universally to possibly identify sub-groups within the disease and possibly target research for more selective therapy for each group?
  • asked a question related to Neurological Diseases
Question
18 answers
To be specific, if a patient has bilateral optic neuritis with positive NMO IgG and asymptomatic spinal cord lesions > 3 segments, is it NMO or NMOSD?
Relevant answer
Answer
In the first place a patient with NMO IgG positive and bilateral OPN is definitely part of the NMOSD and should be treated long term with immunosupression. However myelitis in NMO is unlikely to be asymptomatic. They are lengthy tumifactive lesions and will not remain silent.
  • asked a question related to Neurological Diseases
Question
3 answers
If so, you might be interested in our development of such future devices.
We are a university group and think about starting a company in future. Don´t worry, this is not an advertising or so, I do not want to sell you anything.
We would just like to cordially invite you to take part in a very short poll to get very first impressions of the academics´ and other professionals´ needs.
Please answer six short questions regarding the academic and the pharmaceutical version we have in mind. This takes just five minutes of your time per poll.
For you convenience, you can use the following two survey links:
For the ACADEMIC system (LOW throughput, SEMI-AUTOMATED):
For the PHARMACEUTICAL system (HIGHER throughput, FULLY AUTOMATED):
Let´s shape the future of patch clamp analysis together! You are free to leave your personal data, if you would like to test our prototypes in future (2-3 years)! You can visit our university project site on the following website link:
Relevant answer
Answer
Hi Gabriele,
the mentioned nanion products do not allow for the analysis of cellular networks. This product family and ALL other APC systems availbale were developed and optimized for cells in suspension, cells freshly detached from culture flasks or cells from thawn vials. These APCs cannot analyze cultured cellular networks and were not built for that issue. Let me know if that´s not right.
Don´t get me wrong, nanion and the other APC producers did a great job with their APC development. Chapeau! The devices are great if you need higher troughput. I guess the new nanion 384-channel machine will have a good response in the market. Congrats to nanion!
But if you need network data or a higher organisation grade like in a cell network (some ion channels are only expressed when the cells are attached to a substrate or to other cells...) or in a brain slice, you are limited to manual patch clamp. And we all now that using a manual rig does not allow for higher throughput (5-20 data points per day if you are very experienced). Hence, we believe (and know from our potential customers already) that our future systems are complementary to conventional APCs. Further, our system will drastically increase the parallel number of patched cells, up to 16 at once with one chip! If we get that done: world record! I am sure that the information of the cell-cell-communication analyzed with our systems will be of very high value in future.
By the way, Prof. Markram´s 1 billion € project uses a 12-channel setup (http://www.2045.com/news/31235.html). The rig can be seen in the last figure in this article. The parallel patch clamp of neurons is an important tool for his research.
Well, with our short survey we would like to know the point of view of scientists regarding our technology to define our product development when we start our company in future.
For further information, please contact me under philipp.koester@uni-rostock.de
Best regards, Philipp
  • asked a question related to Neurological Diseases
Question
5 answers
We have used the model of four soft knots on the sciatic nerve and the model of four soft knots on the saphenous nerve, but were unable to generate the expected hyperalgesia. Animals exhibited no significant changes and sometimes presented hypoesthesia.
Relevant answer
Answer
It depends upon what you want to investigate and your expertise. Several "good" models of sicatic nerve lesions have been used to study neuropathic pain, and most are useful. Particularly the spared nerve injury is probably the most consistent in terms of results. What is also very important is to use adequate methods for evaluation. I would not recommend the hot plate. Algesimetry tests for mechanical (Von Frey) and thermal (plantar) focal stimulation are adequate. However, you have to be aware of the innervation territories of the limbs and which areas are denervated or innervated in the surgical model you use. You may take a look at our recent article Cobianchi et al Exp Neurol 2014, 255:1-11.
  • asked a question related to Neurological Diseases
Question
1 answer
Dalakas has given 5 criteria but its not mentioned whether all should be present for diagnosis.
Relevant answer
Answer
Dear Venugopalan,
To my knowledge all criteria should be satisfied to diagnose the Stiff Person Syndrome (formerly known as the Stiff Man Syndrome). These criteria have been satisfied in the three patients I had to deal with and I believe are common to all patients with SPS.
Currently accepted clinical criteria for the diagnosis of stiff-person syndrome :
(1) insidious onset of muscular rigidity with difficulty turning or bending, with rigidity most prominent in the limbs and axial muscles, especially abdominal and thoracolumbar;
(2) co-contraction of agonist and antagonist muscles, confirmed clinically and electrophysiologically;
(3) episodic spasms superimposed on the underlying rigidity, precipitated by noise, tactile stimuli, or emotional upset;
(4) absence of other neurologic or other diseases that could explain the symptoms
May be you can use this paper:
Hoping to have been of any help,
Best Regards,
Ilir Alimehmeti
  • asked a question related to Neurological Diseases
Question
2 answers
Does neuroinflammation and neurodegeneration induced by continuous infusion (intracerebroventricular) of LPS occur in all CNS neurons or only in specific regions? The literature is rich in research about the hippocampus, but not on other regions. I have special interest in the hypothalamus.
Relevant answer
Answer
As you know LPS mediated inflammation is closely associated with nitric oxide production and up regulation of iNOS production at most sites all of which has considerable publications documenting LPS effect on inflammation. Other mediators also play a role. Systemic administration of LPS also produces change in the Nucleus Tractus Solitarii. There is a lot of literature supporting communication pathways between the immune system and brain. I have attached one for your consideration. You are treading on unknown territory as best I know and very interesting work, I look forward to hearing more.
  • asked a question related to Neurological Diseases
Question
11 answers
How to carry out In-Vitro evaluation for Alzheimer disease (both cell line and enzyme inhibition assay)?
Relevant answer
Answer
There is many factor that simulateneously involved in AD. To check these you must go with antioxidant, AchE, LOX, Amyloid Protein cell line protection assay, serotin assay and many more in vitro assay.
  • asked a question related to Neurological Diseases
Question
6 answers
Substantia nigra.
Relevant answer
Answer
To locate any small brain part, first you have to under stand the rat brain atlus in coronal sections. The main part on the coronal section is the varying size of the hippocampus. Hippocampus starts from the optic chiasmaa in small size and as the sections proceed to posterior it goes down and down and make a complete half ring or comma like structure on both side of the hemisphere. You may easily locate the position of the substantia nigra. The rats brain atlus and abbreviation used for the substantia nigra has been pointed out by Dr. Sushil Kumar.
  • asked a question related to Neurological Diseases
Question
2 answers
Diabetic Neuropathy has been on the rise worldwide. Some scientists claim that the copper deficit is also a factor to consider for its etiology.
Relevant answer
Respectfully, the page no longer exists. Http://pmj.bmj.com/content/74/877/665.short
  • asked a question related to Neurological Diseases
Question
1 answer
I’m looking for evidence research and treatment opinions for a rise in sympathetic muscle tone during sleep (4am) and potential with irritated nervous tissue “lose” the adaptive potential that makes sleep “possible”.
Relevant answer
Answer
I am interested in enabling pt to create their own strategy to allow good rest, whether asleep or not, and down regulating their sympathetic nervous system, often gives them the first deep sleep for a long time. Do you know of any studies using an intervention to address sleep impairment in people with chronic pain?
Recent studies indicate that sleep impairment is a predictor of future incidents of chronic pain and that sleep deficits are a stronger, more reliable predictor of pain than pain is of sleep deficits. Finan, Goodin and Smith (2013) suggest additional research into how different chronic pain conditions are affected by changes in sleep, which may give further insight into the mechanisms involved, for example, how chronic pain is affected by forced wakefulness or fragmented sleep. Dopaminergic signalling also may play an important role in contributing to sleep deficits seen in chronic pain sufferers. This suggests that chronic pain that also disturbs sleep, could further lead to dysregulation of the sleep-wake cycle.
From a day to day perspective, the temporal effect of sleep on pain may be stronger than that of pain on sleep. Experimental studies outlined in the review indicate that sleep disturbance has a substantial effect on pain perception as chronic sleep deprivation and was likely to correlate with increased pain sensitivity, and further, that extended sleep within the same population promoted reduced pain sensitivity. From a clinical standpoint, addressing sleep quality deficits may be worthwhile in the efforts to treat and prevent chronic pain. This view is further supported by findings that reduced sleep efficiency also reduces the efficacy of analgesics used in chronic pain patients, in particular, the use of endogenous opioid-mediated pain inhibition.
Research on the contribution of mood to the relationship between pain and sleep quality was also explored. Sleep, pain and the influence of positive or negative affect have been shown to be related; however various methodologies and the lack of any identifiable antecedent in the mood-sleep-pain pathway make the drawing of conclusions difficult.
  • asked a question related to Neurological Diseases
Question
1 answer
I read that the brief repeatable battery of neuropsychological tests, developed by Dr Rao, comes in two different forms. I am particularly interested in the two forms of the SDMT developed for the battery, but can't find them anywhere. Any help?
Relevant answer
Answer
You can request the manual and forms from Dr. Rao (raos2@ccf.org).
  • asked a question related to Neurological Diseases
Question
3 answers
I would like to know the frequency (percentage) of each location (periventricular, cerebellar, spinal, etc).
  • asked a question related to Neurological Diseases
Question
13 answers
We have a clinical problem with a patient with GBS treated promptly with IVIGS. The EMG examination talks about acute motor sensory axonal polineuropathy (AMSAN) with deteriorating clinical course from the first EMG examination. Now the patient is on mechanical ventilation and has no acute infections. At the moment, they have disautonomy and tetraparesia. 21 days ago they received 2 gr/kg in five days of IVIGS. What would you do now?
Nothing,
A second course of IVIGS,
Plasmapheresis?
Relevant answer
Answer
Thanks for all your opinions, but the Guidelines on the Use of Therapeutic Apheresis in Clinical Practice (Journal of Clinical Apheresis 28: 145-284 (2013) says with GRADE methodology that is 2C ( very weak)...